10 Best Undervalued Stocks With Great Momentum for November 2025
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Market Overview & Selection Criteria
The current market landscape is shaped by robust earnings growth in technology, ongoing innovation in healthcare, and shifting dynamics in global commodities. ValueSense’s stock selection methodology leverages a blend of quantitative and qualitative analysis, focusing on intrinsic value, quality ratings, and momentum. The platform’s proprietary tools screen for undervalued stocks with strong fundamentals, high return on invested capital (ROIC), and favorable growth trajectories[1][2]. Each pick is evaluated for sector leadership, financial health, and alignment with long-term value investing principles.
Featured Stock Analysis
Stock #1: Taiwan Semiconductor Manufacturing Company Limited (TSM)
| Metric | Value |
|---|---|
| Market Cap | $1,558.3B |
| Quality Rating | 8.2 |
| Intrinsic Value | $415.7 |
| 1Y Return | 58.1% |
| Revenue | NT$3,631.4B |
| Free Cash Flow | NT$889.9B |
| Revenue Growth | 37.0% |
| FCF margin | 24.5% |
| Gross margin | 59.0% |
| ROIC | 36.2% |
| Total Debt to Equity | 19.0% |
Investment Thesis
TSMC stands as the world’s leading pure-play semiconductor foundry, powering global innovation in AI, mobile, and high-performance computing. With a market cap of $1,558.3B and a ValueSense quality rating of 8.2, TSMC combines scale, technological leadership, and robust financials. The company’s intrinsic value is estimated at $415.7, suggesting potential upside relative to prevailing market prices. Over the past year, TSMC delivered a 58.1% return, underpinned by NT$3,631.4B in revenue and a free cash flow of NT$889.9B. Its 37.0% revenue growth and 24.5% FCF margin highlight operational excellence, while a 59.0% gross margin and 36.2% ROIC underscore efficient capital deployment.
Key Catalysts
- Ongoing global demand for advanced chips in AI, automotive, and IoT
- Expansion into 3nm and 2nm process technologies
- Strategic partnerships with leading tech firms
- Strong pricing power and supply chain resilience
Risk Factors
- Geopolitical tensions impacting Taiwan and global supply chains
- Cyclical semiconductor industry dynamics
- High capital expenditure requirements for technology upgrades
Stock #2: Alibaba Group Holding Limited (BABA)
| Metric | Value |
|---|---|
| Market Cap | $393.8B |
| Quality Rating | 6.2 |
| Intrinsic Value | $471.6 |
| 1Y Return | 73.9% |
| Revenue | CN¥1,000.8B |
| Free Cash Flow | CN¥25.9B |
| Revenue Growth | 5.3% |
| FCF margin | 2.6% |
| Gross margin | 41.2% |
| ROIC | 15.8% |
| Total Debt to Equity | 21.2% |
Investment Thesis
Alibaba is a dominant force in China’s e-commerce and cloud computing sectors, with a $393.8B market cap and a ValueSense quality rating of 6.2. The company’s intrinsic value is calculated at $471.6, and it has posted a remarkable 73.9% 1-year return. Alibaba’s revenue reached CN¥1,000.8B, with free cash flow at CN¥25.9B. While revenue growth has moderated to 5.3%, the company maintains a solid 41.2% gross margin and 15.8% ROIC, reflecting resilience amid regulatory and competitive pressures.
Key Catalysts
- Recovery in Chinese consumer spending and digital adoption
- Expansion of cloud services and international e-commerce
- Strategic investments in logistics and fintech
Risk Factors
- Regulatory scrutiny in China and abroad
- Intensifying competition from domestic and global players
- Currency and macroeconomic volatility
Stock #3: Cisco Systems, Inc. (CSCO)
| Metric | Value |
|---|---|
| Market Cap | $289.5B |
| Quality Rating | 6.6 |
| Intrinsic Value | $78.2 |
| 1Y Return | 34.4% |
| Revenue | $56.7B |
| Free Cash Flow | $13.3B |
| Revenue Growth | 5.3% |
| FCF margin | 23.5% |
| Gross margin | 65.1% |
| ROIC | 13.3% |
| Total Debt to Equity | 63.3% |
Investment Thesis
Cisco is a global leader in networking hardware and enterprise IT solutions, with a $289.5B market cap and a ValueSense quality rating of 6.6. The company’s intrinsic value is $78.2, and it has delivered a 34.4% 1-year return. Cisco’s $56.7B in revenue and $13.3B in free cash flow are supported by a 5.3% revenue growth rate, 23.5% FCF margin, and an industry-leading 65.1% gross margin. Its 13.3% ROIC and moderate leverage (63.3% debt to equity) reflect a balanced capital structure.
Key Catalysts
- Rising demand for secure, scalable networking solutions
- Growth in cloud, cybersecurity, and subscription-based services
- Strategic acquisitions to expand product portfolio
Risk Factors
- Competitive pressures from emerging networking technologies
- Macroeconomic headwinds affecting enterprise IT spending
- Currency fluctuations impacting global revenues
Stock #4: Micron Technology, Inc. (MU)
| Metric | Value |
|---|---|
| Market Cap | $249.7B |
| Quality Rating | 8.4 |
| Intrinsic Value | $368.6 |
| 1Y Return | 124.8% |
| Revenue | $37.4B |
| Free Cash Flow | $8,929.0M |
| Revenue Growth | 48.9% |
| FCF margin | 23.9% |
| Gross margin | 39.8% |
| ROIC | 15.9% |
| Total Debt to Equity | 27.2% |
Investment Thesis
Micron is a leading provider of memory and storage solutions, with a $249.7B market cap and a ValueSense quality rating of 8.4—the highest in this collection. The company’s intrinsic value is $368.6, and it has achieved a stellar 124.8% 1-year return. Micron generated $37.4B in revenue and $8,929.0M in free cash flow, with 48.9% revenue growth and a 23.9% FCF margin. Its 39.8% gross margin and 15.9% ROIC highlight strong profitability and capital efficiency.
Key Catalysts
- Surging demand for DRAM and NAND in AI, cloud, and automotive
- Product innovation in high-bandwidth memory
- Strategic supply agreements with major OEMs
Risk Factors
- Volatility in memory pricing cycles
- Capital intensity of semiconductor manufacturing
- Exposure to global supply chain disruptions
Stock #5: Shell plc (SHEL)
| Metric | Value |
|---|---|
| Market Cap | $222.8B |
| Quality Rating | 6.2 |
| Intrinsic Value | $107.1 |
| 1Y Return | 13.3% |
| Revenue | $272.0B |
| Free Cash Flow | $28.7B |
| Revenue Growth | (9.9%) |
| FCF margin | 10.5% |
| Gross margin | 18.5% |
| ROIC | 10.5% |
| Total Debt to Equity | 41.3% |
Investment Thesis
Shell is a global energy major with a $222.8B market cap and a ValueSense quality rating of 6.2. The company’s intrinsic value is $107.1, and it has posted a 13.3% 1-year return. Shell reported $272.0B in revenue and $28.7B in free cash flow. Despite a 9.9% revenue decline, the company maintains a 10.5% FCF margin and 18.5% gross margin. Its 10.5% ROIC and 41.3% debt to equity reflect a stable, diversified business model.
Key Catalysts
- Transition to renewable energy and low-carbon solutions
- Strong cash flows supporting dividends and buybacks
- Strategic asset divestitures and portfolio optimization
Risk Factors
- Commodity price volatility
- Regulatory and environmental risks
- Capital allocation challenges in energy transition
Stock #6: Uber Technologies, Inc. (UBER)
| Metric | Value |
|---|---|
| Market Cap | $201.9B |
| Quality Rating | 7.5 |
| Intrinsic Value | $201.7 |
| 1Y Return | 33.9% |
| Revenue | $47.3B |
| Free Cash Flow | $8,540.0M |
| Revenue Growth | 18.2% |
| FCF margin | 18.0% |
| Gross margin | 39.7% |
| ROIC | 66.4% |
| Total Debt to Equity | 52.2% |
Investment Thesis
Uber is a global mobility and delivery platform with a $201.9B market cap and a ValueSense quality rating of 7.5. The company’s intrinsic value is $201.7, and it has delivered a 33.9% 1-year return. Uber’s $47.3B in revenue and $8,540.0M in free cash flow are driven by 18.2% revenue growth and an 18.0% FCF margin. Its 39.7% gross margin and an exceptional 66.4% ROIC reflect operational leverage and capital efficiency.
Key Catalysts
- Expansion of mobility and delivery services globally
- Growth in advertising and new verticals
- Operating leverage from platform scale
Risk Factors
- Regulatory challenges in key markets
- Competitive pressures in ride-hailing and delivery
- Exposure to macroeconomic cycles
Stock #7: Intel Corporation (INTC)
| Metric | Value |
|---|---|
| Market Cap | $180.5B |
| Quality Rating | 5.1 |
| Intrinsic Value | $74.5 |
| 1Y Return | 85.8% |
| Revenue | $53.4B |
| Free Cash Flow | ($7,251.0M) |
| Revenue Growth | (1.5%) |
| FCF margin | (13.6%) |
| Gross margin | 35.8% |
| ROIC | (1.3%) |
| Total Debt to Equity | 39.9% |
Investment Thesis
Intel is a foundational player in global semiconductors, with a $180.5B market cap and a ValueSense quality rating of 5.1. The company’s intrinsic value is $74.5, and it has posted an 85.8% 1-year return. Intel’s $53.4B in revenue is offset by negative free cash flow (–$7,251.0M) and a 1.5% revenue decline. The company’s 35.8% gross margin and 1.3% ROIC reflect ongoing challenges in profitability and capital allocation.
Key Catalysts
- Investment in advanced manufacturing and foundry services
- Strategic partnerships and government incentives
- Product roadmap in AI and data center chips
Risk Factors
- Execution risk in technology transitions
- Intense competition from global peers
- Margin pressure from high capital expenditures
Stock #8: Unilever PLC (UL)
| Metric | Value |
|---|---|
| Market Cap | $148.9B |
| Quality Rating | 7.3 |
| Intrinsic Value | $95.9 |
| 1Y Return | 0.4% |
| Revenue | €120.1B |
| Free Cash Flow | €14.5B |
| Revenue Growth | 2.5% |
| FCF margin | 12.1% |
| Gross margin | 71.3% |
| ROIC | 32.1% |
| Total Debt to Equity | 160.7% |
Investment Thesis
Unilever is a global consumer goods leader with a $148.9B market cap and a ValueSense quality rating of 7.3. The company’s intrinsic value is $95.9, and it has delivered a modest 0.4% 1-year return. Unilever’s €120.1B in revenue and €14.5B in free cash flow are supported by a 2.5% revenue growth rate and a 12.1% FCF margin. Its 71.3% gross margin and 32.1% ROIC highlight strong brand equity and capital efficiency.
Key Catalysts
- Portfolio of leading brands in food, home, and personal care
- Expansion in emerging markets
- Focus on sustainability and digital transformation
Risk Factors
- Currency and inflationary pressures
- Shifting consumer preferences
- High leverage (160.7% debt to equity)
Stock #9: Anheuser-Busch InBev SA/NV (BUD)
| Metric | Value |
|---|---|
| Market Cap | $121.4B |
| Quality Rating | 7.1 |
| Intrinsic Value | $71.9 |
| 1Y Return | 2.6% |
| Revenue | $73.5B |
| Free Cash Flow | $11.7B |
| Revenue Growth | 22.7% |
| FCF margin | 15.9% |
| Gross margin | 55.7% |
| ROIC | 17.3% |
| Total Debt to Equity | 82.7% |
Investment Thesis
Anheuser-Busch InBev is a global brewing giant with a $121.4B market cap and a ValueSense quality rating of 7.1. The company’s intrinsic value is $71.9, and it has posted a 2.6% 1-year return. BUD’s $73.5B in revenue and $11.7B in free cash flow are driven by 22.7% revenue growth and a 15.9% FCF margin. Its 55.7% gross margin and 17.3% ROIC reflect scale and operational efficiency.
Key Catalysts
- Global brand portfolio and distribution reach
- Growth in premium and non-alcoholic beverages
- Margin expansion through cost initiatives
Risk Factors
- Regulatory and health-related challenges
- Currency volatility in emerging markets
- High leverage (82.7% debt to equity)
Stock #10: Medtronic plc (MDT)
| Metric | Value |
|---|---|
| Market Cap | $116.2B |
| Quality Rating | 6.7 |
| Intrinsic Value | $120.6 |
| 1Y Return | 2.5% |
| Revenue | $34.2B |
| Free Cash Flow | $5,303.0M |
| Revenue Growth | 5.0% |
| FCF margin | 15.5% |
| Gross margin | 63.4% |
| ROIC | 8.2% |
| Total Debt to Equity | 59.4% |
Investment Thesis
Medtronic is a global leader in medical devices, with a $116.2B market cap and a ValueSense quality rating of 6.7. The company’s intrinsic value is $120.6, and it has delivered a 2.5% 1-year return. Medtronic’s $34.2B in revenue and $5,303.0M in free cash flow are supported by 5.0% revenue growth and a 15.5% FCF margin. Its 63.4% gross margin and 8.2% ROIC reflect a strong competitive position in healthcare technology.
Key Catalysts
- Innovation in minimally invasive and robotic surgery
- Expansion in emerging healthcare markets
- Aging global population driving demand
Risk Factors
- Regulatory and reimbursement risks
- Competitive pressures in medtech
- Moderate leverage (59.4% debt to equity)
Portfolio Diversification Insights
This collection spans technology (TSM, MU, INTC, CSCO), consumer (UL, BUD), healthcare (MDT), energy (SHEL), mobility (UBER), and e-commerce (BABA). The allocation balances high-growth technology with stable consumer and healthcare names, while energy and mobility provide exposure to cyclical and secular trends. Such diversification helps mitigate sector-specific risks and enhances the portfolio’s resilience to market volatility.
Market Timing & Entry Strategies
Investors may consider phased entry strategies, such as dollar-cost averaging, to manage volatility and avoid market timing pitfalls. Monitoring earnings releases, macroeconomic data, and sector-specific news can help identify optimal entry points. ValueSense’s intrinsic value tools and backtesting features support disciplined, data-driven decision-making[1][2].
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2025)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!
More Articles You Might Like
- How VKTX (Viking Therapeutics) Makes Money in 2025: A Deep-Dive With Income Statement
- How NET (Cloudflare) Makes Money in 2025: A Deep-Dive With Income Statement
- How MASS (908 Devices) Makes Money in 2025: A Deep-Dive With Income Statement
- How CRVO (CervoMed) Makes Money in 2025: A Deep-Dive With Income Statement
- How GILD (Gilead Sciences) Makes Money in 2025: A Deep-Dive With Income Statement
FAQ Section
Q1: How were these stocks selected?
Stocks were chosen using ValueSense’s proprietary screening tools, focusing on intrinsic value, quality ratings, financial health, and growth momentum. The platform combines quantitative metrics with AI-driven qualitative analysis for a comprehensive selection process[1][2].
Q2: What's the best stock from this list?
Each stock offers unique strengths; for example, Micron (MU) and TSMC (TSM) stand out for high quality ratings and strong returns, while Unilever (UL) and Shell (SHEL) provide stability. The “best” stock depends on individual investment goals and risk tolerance.
Q3: Should I buy all these stocks or diversify?
Diversification across sectors—technology, healthcare, consumer, energy—can help reduce risk and smooth returns. ValueSense’s watchlist is designed to offer a balanced mix for educational portfolio construction.
Q4: What are the biggest risks with these picks?
Risks include sector-specific headwinds (e.g., regulatory, geopolitical, commodity price volatility), company execution, and broader market cycles. Each stock’s risk profile is detailed in its analysis above.
Q5: When is the best time to invest in these stocks?
There is no universally “best” time; disciplined strategies like dollar-cost averaging and monitoring for valuation gaps using ValueSense’s intrinsic value tools can help guide entry decisions.